Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving drugs in different ways may
kill more tumor cells. It is not yet known whether fluorouracil plus cisplatin are more
effective than fluorouracil alone in treating patients with metastatic cancer of the
pancreas.
PURPOSE: Randomized phase III trial to compare the effectiveness of fluorouracil with or
without cisplatin in treating patients who have advanced or metastatic cancer of the
pancreas.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC